Volitionrx (VNRX) Change in Accured Expenses (2011 - 2025)
Volitionrx's (VNRX) quarterly Change in Accured Expenses came in at -$726215.0 in Q4 2025, up 9.29% YoY from -$664460.8 in Q4 2024, and down 173.13% on a QoQ basis from $993076.0 in Q3 2025.
Volitionrx (VNRX) Change in Accured Expenses (2011 - 2025) Analysis & Trends
Volitionrx (VNRX) has 15 years of Change in Accured Expenses data on file, last reported at -$726215.0 in Q4 2025.
- Quarterly Change in Accured Expenses rose 9.29% year-over-year to -$726215.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $77977.0 (up 106.41% YoY) and the FY2025 annual result came in at $77977.0, up 106.41% from the prior year.
- Change in Accured Expenses eased to -$726215.0 in Q4 2025, from $993076.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $1.2 million in Q4 2023 to a low of -$949636.0 in Q3 2023.
- A 5-year average of $57826.9 and a median of -$14238.5 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2021 — Change in Accured Expenses tumbled 643.52% — and 2023, when it surged 36151.57%.
- Tracing VNRX's Change in Accured Expenses over 5 years: stood at $549403.0 in 2021, then sank by 99.39% to $3345.0 in 2022, then surged by 36151.57% to $1.2 million in 2023, then slumped by 166.02% to -$800624.0 in 2024, then increased by 9.29% to -$726215.0 in 2025.
- The last three Change in Accured Expenses figures came in at -$726215.0 (Q4 2025), $993076.0 (Q3 2025), and -$560926.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Volitionrx | 1.19 Mn | -1.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -726,215.00 |
| Dec 31, 2025 | -726,215.00 |
| Sep 30, 2025 | 993,076.00 |
| Sep 30, 2025 | 993,076.00 |
| Jun 30, 2025 | -560,926.00 |
| Jun 30, 2025 | -560,926.00 |
| Mar 31, 2025 | 372,042.00 |
| Mar 31, 2025 | 372,042.00 |
| Dec 31, 2024 | -800,624.00 |
| Dec 31, 2024 | -800,624.00 |
| Sep 30, 2024 | -31,822.00 |
| Sep 30, 2024 | -31,822.00 |
| Jun 30, 2024 | -396,322.00 |
| Jun 30, 2024 | -396,322.00 |
| Mar 31, 2024 | 11,755.00 |
| Mar 31, 2024 | 11,755.00 |
| Dec 31, 2023 | 1.21 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | -949,636.00 |
| Sep 30, 2023 | -949,636.00 |